• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌二醇金属螯合物和雌激素受体复合物的结构:设计新型选择性雌激素受体调节剂的基础。

Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators.

机构信息

Department of Structural Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

出版信息

J Med Chem. 2011 May 26;54(10):3575-80. doi: 10.1021/jm200192y. Epub 2011 Apr 19.

DOI:10.1021/jm200192y
PMID:21473635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3112352/
Abstract

Selective estrogen receptor modulators, such as 17β-estradiol derivatives bound to metal complexes, have been synthesized as targeted probes for the diagnosis and treatment of breast cancer. Here, we report the detailed 3D structure of estrogen receptor α ligand-binding domain (ERα-LBD) bound with a novel estradiol-derived metal complex, estradiol-pyridine tetra acetate europium(III), at 2.6 Å resolution. This structure provides important information pertinent to the design of novel functional ERα targeted probes for clinical applications.

摘要

选择性雌激素受体调节剂,如与金属配合物结合的 17β-雌二醇衍生物,已被合成为用于诊断和治疗乳腺癌的靶向探针。在这里,我们报告了与新型雌二醇衍生的金属配合物,即雌二醇-吡啶四乙酸铕(III)结合的雌激素受体 α 配体结合域(ERα-LBD)的详细 3D 结构,分辨率为 2.6Å。该结构提供了与设计用于临床应用的新型功能性 ERα 靶向探针相关的重要信息。

相似文献

1
Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators.雌二醇金属螯合物和雌激素受体复合物的结构:设计新型选择性雌激素受体调节剂的基础。
J Med Chem. 2011 May 26;54(10):3575-80. doi: 10.1021/jm200192y. Epub 2011 Apr 19.
2
Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.具有构象受限侧链的选择性雌激素受体调节剂。雌激素受体α选择性四氢异喹啉配体的合成与构效关系。
J Med Chem. 2005 Jan 27;48(2):364-79. doi: 10.1021/jm040858p.
3
Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.苯妥英是一种雌激素受体 α 选择性调节剂,与螺旋 12 相互作用。
Reprod Sci. 2015 Feb;22(2):146-55. doi: 10.1177/1933719114549853. Epub 2014 Sep 25.
4
Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.雌激素受体 α L543A、L544A 突变将拮抗剂转化为激动剂,与配体结合域二聚化相关,从而与 DNA 结合活性相关联。
J Biol Chem. 2013 Jul 19;288(29):21105-21116. doi: 10.1074/jbc.M113.463455. Epub 2013 Jun 3.
5
Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.雌激素受体α的构象动力学:结合位点结构对蛋白质动力学影响的分子动力学模拟
Biochemistry. 2007 Feb 20;46(7):1743-58. doi: 10.1021/bi061656t. Epub 2007 Jan 24.
6
Structural basis for an unexpected mode of SERM-mediated ER antagonism.选择性雌激素受体调节剂(SERM)介导的雌激素受体(ER)拮抗作用的意外模式的结构基础。
Mol Cell. 2005 May 13;18(4):413-24. doi: 10.1016/j.molcel.2005.04.014.
7
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics.选择性雌激素受体调节剂在人乳腺癌细胞中活性的分子机制:通过相互作用蛋白质组学鉴定抗雌激素-ERα 复合物的新型核共因子。
J Proteome Res. 2013 Jan 4;12(1):421-31. doi: 10.1021/pr300753u. Epub 2012 Nov 30.
8
Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.合成及生化鉴定一系列 17α-全氟烷基化雌二醇作为雌激素受体 α 的选择性配体。
J Med Chem. 2010 Oct 14;53(19):6947-53. doi: 10.1021/jm100563h.
9
Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.白藜芦醇对雌激素受体α的拮抗剂和部分激动剂作用的结构见解。
BMC Struct Biol. 2013 Oct 25;13:27. doi: 10.1186/1472-6807-13-27.
10
New scaffolds for the design of selective estrogen receptor modulators.用于设计选择性雌激素受体调节剂的新型支架
Org Biomol Chem. 2008 Oct 7;6(19):3486-96. doi: 10.1039/b806918b. Epub 2008 Aug 4.

引用本文的文献

1
Crystal structure, Hirshfeld surface analysis, DFT optimized mol-ecular structure and the mol-ecular docking studies of 1-[2-(cyano-sulfan-yl)acet-yl]-3-methyl-2,6-bis-(4-methyl-phen-yl)piperidin-4-one.1-[2-(氰硫基)乙酰基]-3-甲基-2,6-双(4-甲基苯基)哌啶-4-酮的晶体结构、 Hirshfeld表面分析、密度泛函理论(DFT)优化的分子结构及分子对接研究
Acta Crystallogr E Crystallogr Commun. 2024 Sep 12;80(Pt 10):1014-1019. doi: 10.1107/S2056989024008508. eCollection 2024 Sep 1.
2
Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents.新型熊果酸衍生物的合成、生物活性、ADME 和分子对接研究及其作为潜在抗癌药物的应用。
Int J Mol Sci. 2023 May 17;24(10):8875. doi: 10.3390/ijms24108875.
3

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
PHENIX: a comprehensive Python-based system for macromolecular structure solution.PHENIX:一个基于Python的用于大分子结构解析的综合系统。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. doi: 10.1107/S0907444909052925. Epub 2010 Jan 22.
3
MolProbity: all-atom structure validation for macromolecular crystallography.MolProbity:用于大分子晶体学的全原子结构验证
Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells.甾体嘧啶和二氢三嗪作为针对激素依赖性乳腺癌细胞的新型抗癌剂。
Front Pharmacol. 2018 Jan 10;8:979. doi: 10.3389/fphar.2017.00979. eCollection 2017.
4
Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.用于乳腺癌激素状态分子磁共振成像的雌激素受体靶向造影剂。
Front Oncol. 2016 Apr 27;6:100. doi: 10.3389/fonc.2016.00100. eCollection 2016.
5
Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.用于预测雌激素受体亚型α激动剂和拮抗剂的竞争性分子对接方法。
BMC Bioinformatics. 2014;15 Suppl 11(Suppl 11):S4. doi: 10.1186/1471-2105-15-S11-S4. Epub 2014 Oct 21.
6
Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands.通用性还是混杂性:雌激素受体、配体选择性的控制及亚型选择性配体的最新进展
Int J Environ Res Public Health. 2014 Aug 26;11(9):8709-42. doi: 10.3390/ijerph110908709.
7
Histone deacetylase inhibitors equipped with estrogen receptor modulation activity.具有雌激素受体调节活性的组蛋白去乙酰化酶抑制剂。
J Med Chem. 2013 Jul 25;56(14):5782-96. doi: 10.1021/jm400467w. Epub 2013 Jul 3.
8
Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor.非甾体双价雌激素配体:双价概念在雌激素受体中的应用。
ACS Chem Biol. 2013 Apr 19;8(4):707-15. doi: 10.1021/cb3006243. Epub 2013 Jan 30.
9
Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.在溶液、乳腺癌细胞和体内肿瘤中对雌激素受体靶向对比剂进行表征。
Magn Reson Med. 2013 Jul;70(1):193-206. doi: 10.1002/mrm.24442. Epub 2012 Aug 10.
10
Structure - relaxivity relationships among targeted MR contrast agents.靶向磁共振造影剂的结构-弛豫率关系
Eur J Inorg Chem. 2012 Apr;2012(12):1916-1923. doi: 10.1002/ejic.201101364.
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. doi: 10.1107/S0907444909042073. Epub 2009 Dec 21.
4
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation.电子配体构建器与优化工作台(eLBOW):一种用于生成配体坐标和约束的工具。
Acta Crystallogr D Biol Crystallogr. 2009 Oct;65(Pt 10):1074-80. doi: 10.1107/S0907444909029436. Epub 2009 Sep 16.
5
Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.配体从雌激素受体上的脱离:对途径和配体特异性的计算研究。
Proteins. 2009 Dec;77(4):842-56. doi: 10.1002/prot.22503.
6
Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.雌激素受体配体解离机制及选择性的计算洞察
J Phys Chem B. 2009 Jul 30;113(30):10436-44. doi: 10.1021/jp903785h.
7
Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.配体从雌激素受体的解离是由受体二聚化介导的:来自分子动力学模拟的证据。
Mol Endocrinol. 2008 Jul;22(7):1565-78. doi: 10.1210/me.2007-0501. Epub 2008 Apr 10.
8
Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol.通过去酰基可的唑使糖皮质激素受体配体结合口袋的大小加倍。
Mol Cell Biol. 2008 Mar;28(6):1915-23. doi: 10.1128/MCB.01541-07. Epub 2007 Dec 26.
9
Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging.用于分子磁共振成像的靶向雌激素受体的水溶性造影剂。
Bioconjug Chem. 2007 Sep-Oct;18(5):1361-5. doi: 10.1021/bc700230m. Epub 2007 Sep 5.
10
Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents.孕酮修饰的磁共振成像造影剂的合理设计、合成及生物学评价
Chem Biol. 2007 Jul;14(7):824-34. doi: 10.1016/j.chembiol.2007.06.006.